Microsclerotherapy: A Practical Training Guide for Doctors and Nurses Learning to Treat Spider Veins

Microsclerotherapy is one of the most useful skills a clinician can add to a cosmetic vein practice. It is widely used as an office-based treatment for spider veins and small reticular veins, and reputable clinical references describe it as a core treatment approach for small visible veins. See StatPearls, Medscape Guidelines, and the Microsclerotherapy guideline on PMC.

For clinicians learning Microsclerotherapy, the challenge is not just knowing what to inject. The real challenge is injecting accurately, choosing the lowest effective concentration, recognising problems early, and giving patients realistic advice about bruising, pigmentation, compression, and results.

Why Microsclerotherapy matters

Microsclerotherapy remains a core treatment for cosmetic thread veins and small leg spider veins. In practical terms, it gives doctors and nurses a minimally invasive way to treat visible superficial veins without surgery, while also offering a strong foundation for a focused private practice service. Background reading on the role of sclerotherapy can be found in StatPearls and the Mayo Clinic overview.

For training purposes, Microsclerotherapy is especially valuable because it teaches judgement as much as technique. A clinician must assess vein type, choose the right sclerosant and concentration, control hand position and needle angle, and manage patient expectations before, during, and after treatment.

The two main sclerosants

The two sclerosants most commonly used in this setting are polidocanol and sodium tetradecyl sulfate. Both are detergent sclerosants that damage the endothelium, leading to inflammation and eventual fibrosis of the treated vessel. A helpful overview is available in the dermatology sclerotherapy guidelines and StatPearls.

A key practical point is that sodium tetradecyl sulfate is more potent than polidocanol, so concentrations must be adjusted carefully rather than treated as interchangeable. Suggested concentration ranges for telangiectasias and reticular veins are set out in this best-practice microsclerotherapy guide and in the dermatology guideline.

In practical teaching terms, this means:

• Lower concentrations are used for telangiectasias.

• Slightly higher concentrations may be used for reticular veins.

• These are prescription medicines, and clinicians using them must be prepared to manage anaphylaxis.

What makes good injection technique

The core principle is simple: successful microsclerotherapy depends on precision. Good results come from small volumes, gentle injections, low pressure, and constant attention to whether the sclerosant is truly inside the target vessel. The importance of technique, concentration choice, and careful delivery is reflected in the Microsclerotherapy guideline on PMC and StatPearls.

There are also some practical warning signs clinicians should watch for:

• The aim is to blanch the vessel, not the surrounding skin.

• A bleb suggests extravasation and should prompt the injection to stop.

• Blanching of the skin around the injection site is a warning sign and should also prompt the injection to stop immediately.

These principles are consistent with complication-prevention guidance such as the ACE UK microsclerotherapy complications document.

Technique for spider veins and reticular veins

Spider veins

Spider veins, or telangiectasias, are very superficial and sit in the upper dermis. One of the common beginner errors is placing the needle too deep. The need for accurate superficial placement and careful technique is discussed in the Microsclerotherapy guideline on PMC and the best-practice microsclerotherapy guide.

Reticular veins

Reticular veins are deeper than telangiectasias, so the needle angle and handling change. The same sources above are useful for understanding how treatment varies with vessel size and depth, particularly the best-practice guide.

Ergonomics matter more than most clinicians think

Many clinicians focus heavily on the syringe and the vein but underestimate the importance of body position. Poor ergonomics reduce precision, increase fatigue, and can make a long treatment list physically uncomfortable for both clinician and patient. While this point is often under-emphasised in short summaries, it fits with the broader procedural principle that precision and comfort improve outcomes.

Common complications and how to think about them

Two issues dominate patient concern in cosmetic microsclerotherapy: pigmentation and unwanted local reactions from imperfect injections. Reputable references list hyperpigmentation, matting, blistering, superficial thrombophlebitis and, more rarely, ulceration or necrosis among the recognised complications. See the ACE UK microsclerotherapy complications guidance, the BCAM sclerotherapy information page, and StatPearls.

A helpful point for clinicians is that complications are not just about what happens after the injection. They are often linked to assessment, concentration choice, underlying reflux, injection pressure, and aftercare advice.

Aftercare and the compression question

Aftercare advice is one of the most debated parts of cosmetic vein treatment. Walking and return to normal activity are commonly encouraged after sclerotherapy, and many clinicians advise compression stockings for at least a period after treatment. See the Mayo Clinic sclerotherapy page and the Microsclerotherapy guideline on PMC.

At the same time, real-world practice varies, especially for uncomplicated cosmetic thread veins. This means clinicians should avoid presenting aftercare as a rigid one-size-fits-all recipe and instead explain why their own protocol is being used.

Good patient advice usually includes:

• Keep walking and avoid long periods of immobility.

• Stay well hydrated.

• Expect the veins to look worse before they look better.

• Understand that more than one treatment session may be needed.

The point about multiple sessions is also reflected in the Mayo Clinic guidance and this PMC review on spider vein treatment.

What clinicians should document

Good documentation protects both the patient and the practitioner. In practical terms, it is sensible to record the concentration used, total volume, treatment area, immediate patient response, aftercare advice, and any complications or concerns raised during the visit. This fits with good procedural practice and with the emphasis on safety seen in StatPearls and the ACE complications guidance.

A practical training framework for learning Microsclerotherapy

Clinicians learning microsclerotherapy often improve faster when they follow a repeatable framework:

1. Identify whether the target is a telangiectasia or a reticular vein.

2. Choose the lowest effective sclerosant concentration.

3. Position both patient and operator properly before starting.

4. Inject slowly, gently, and with close visual feedback.

5. Stop immediately if there is a bleb or skin blanching.

6. Give realistic aftercare advice and document the session carefully.

This framework reflects the common themes across the major guidance documents: careful patient selection, conservative dosing, accurate injection, complication awareness, and structured follow-up. See StatPearls, the Microsclerotherapy guideline on PMC, and the best-practice microsclerotherapy guide.

Why this matters for a modern cosmetic vein practice

For doctors and nurses building a cosmetic vein service, Microsclerotherapy is not just a technical procedure. It is a clinical skill that depends on judgement, consistency, communication, and good systems.

A strong Microsclerotherapy service also benefits from clear patient education. Pages that explain vein types, treatment steps, aftercare, pigmentation risks, and who the treatment is suitable for are easier for both clinicians and website visitors to understand. They also make your content more useful, more trustworthy, and easier for search engines and AI tools to interpret.

Key takeaways

• Microsclerotherapy is a core office-based treatment for spider veins and reticular veins. See StatPearls and Medscape Guidelines.

• Polidocanol and sodium tetradecyl sulfate are the main sclerosants, but concentrations must be chosen carefully. See the best-practice guide and dermatology guideline.

• Hyperpigmentation, matting and local injection problems are recognised risks and should be explained clearly. See the ACE UK guidance and BCAM page.

• Walking, expectation-setting and thoughtful aftercare remain important parts of the treatment journey. See the Mayo Clinic overview.

Final thought

For clinicians who want to treat leg spider veins well, Microsclerotherapy is a skill worth mastering properly. The basics are straightforward, but the quality of the result depends on how carefully the details are applied.

That is why the best Microsclerotherapy training does more than show where to put the needle. It teaches clinicians how to think clearly about concentration, control, complications, comfort, communication, and follow-up — because that is what turns a procedure into a dependable clinical service.

If you would like to know more about Microsclerotherapy Training then do please get in touch

Microsclerotherapy FAQs

1. What is microsclerotherapy and when should doctors use it for leg spider veins?

Microsclerotherapy is an injection technique used to treat small superficial veins, especially leg spider veins and small reticular veins. A detergent sclerosant is injected directly into the vein, damaging the endothelium and causing the vessel to collapse and be reabsorbed over time.

It is most appropriate for cosmetic leg spider veins and small reticular veins in patients without significant underlying venous disease. Larger varicose veins and symptoms such as swelling, skin changes or ulceration usually need a duplex assessment and possibly endovenous treatment first.

2. Which sclerosants and concentrations are recommended for microsclerotherapy training cases?

The two most commonly used sclerosants are polidocanol and sodium tetradecyl sulfate (STS). Both are detergent sclerosants; STS is more potent, so lower concentrations are required than with polidocanol.

For training cases on uncomplicated leg spider veins, many clinicians start with the lowest effective concentrations recommended in guidelines (for example, low‑strength polidocanol or STS for telangiectasias and slightly higher strengths for reticular veins), then adjust based on vessel size, patient response and local protocols. These medicines are prescription‑only and should only be used by clinicians trained to manage anaphylaxis and other adverse reactions.

3. How many microsclerotherapy sessions do patients usually need for cosmetic spider veins?

Most patients require more than one treatment session. Small, localised spider veins may respond well to one or two sessions, but more extensive networks of veins typically need a short course of treatments spaced several weeks apart.

It is helpful to set expectations from the outset: veins often look worse before they look better because of bruising and trapped blood, and full improvement may take several months after the final session. You can frame microsclerotherapy as a process rather than a one‑off “quick fix”.

4. What are the most common microsclerotherapy complications and how can clinicians reduce the risk?

The most common issues after microsclerotherapy include bruising, temporary discomfort, hyperpigmentation (brown staining) and, occasionally, matting (fine new vessels). More serious but less frequent problems include superficial thrombophlebitis, ulceration from intra‑arterial or extravascular injection, and very rarely allergic or systemic reactions.

Risk can be reduced by using the lowest effective concentration, injecting slowly with small volumes, ensuring the needle tip is inside the vein, avoiding excessive pressure, carefully assessing for underlying reflux, and giving clear aftercare instructions (including walking, leg elevation when appropriate, and prompt reporting of any unusual pain, blistering or colour change). Good documentation and a structured follow‑up plan are also important parts of safe practice.

About the author

This educational article is written and regularly reviewed by Dr Haroun Gajraj, a GMC‑registered vein specialist who has treated thousands of patients with vein disease and has trained many doctors and nurses in microsclerotherapy, shortwave diathermy and related cosmetic vein procedures.

Dr Gajraj is the founder and board member of the British Association of Sclerotherapists.

You can view his current GMC registration and independent patient reviews on iWantGreatCare for further information about his clinical background. It is designed for healthcare professionals and is based on current clinical guidelines, peer‑reviewed research and day‑to‑day practice experience. The information here is general education only and is not a substitute for individual clinical judgement, local protocols or formal training. Clinicians remain responsible for assessing each patient, obtaining informed consent, explaining risks and alternatives, and working within the scope of their professional registration and regulatory guidance.

Subscribe

For regular updates get my weekly newsletter here